Evelo Biosciences

General Information


Evelo Biosciences is discovering and developing potential therapies designed to act on the gut-body network. The action of our therapies is based on our growing understanding of the central role of the gut in controlling immune and biological activity throughout the body. The gut-body network represents the connections of the gut to all organs and tissues, which enables the gut to exert a significant level of control over the body’s immune and biological systems.


Employees: 59
Founded: 2014
Contact Information
Address 620 Memorial Drive, Suite 200, Cambridge, MA 02139, US
Phone Number (617) 577-0300
Web Address http://www.evelobio.com
View Prospectus: Evelo Biosciences
Financial Information
Market Cap $509.9mil
Revenues $0 mil (last 12 months)
Net Income $-34.1 mil (last 12 months)
IPO Profile
Symbol EVLO
Exchange NASDAQ
Shares (millions): 5.3
Price range $16.00 - $16.00
Est. $ Volume $85.0 mil
Manager / Joint Managers Morgan Stanley/ Cowen/ BMO Capital Markets
CO-Managers JMP Securities
Expected To Trade: 5/9/2018
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change